RTTNews | Oct 15, 2021 10:03AM EDT

10:03 Friday, October 15, 2021 (RTTNews.com) - Shares of Jasper Therapeutics, Inc. (JSPR) are continuing their rally from Wednesday when the clinical-stage biotechnology company's stock rose on the news that Oppenheimer initiated coverage on the company with outperform rating. The stock are gaining over 30% on Friday morning.

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies.

JSPR is currently trading at $16.37, up $3.89 or 31.14%, on the Nasdaq.

Read the original article on RTTNews ( https://www.rttnews.com/3233021/jasper-therapeutics-rally-continues-stock-up-30.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved